Budget Matters: Infrastructure to Support Robust Generic Drug Competition

By: Scott Gottlieb, M.D. The FDA launched its Drug Competition Action Plan more than a year ago, with the aim of advancing policies that would promote robust generic drug entry as a way to foster competition and lower drug prices. … Continue reading →
Source: FDA Voice - Category: American Health Source Type: blogs